Pub. Date : 2012 Aug 1
PMID : 22622461
4 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Peroxisome proliferator-activated receptor-alpha (PPARalpha) activation attenuates cisplatin (CP)-mediated acute kidney injury by increasing fatty acid oxidation, but mechanisms leading to reduced renal triglyceride (TG) accumulation could also contribute. | Triglycerides | peroxisome proliferator activated receptor alpha | Mus musculus |
| 2 | Peroxisome proliferator-activated receptor-alpha (PPARalpha) activation attenuates cisplatin (CP)-mediated acute kidney injury by increasing fatty acid oxidation, but mechanisms leading to reduced renal triglyceride (TG) accumulation could also contribute. | Triglycerides | peroxisome proliferator activated receptor alpha | Mus musculus |
| 3 | Peroxisome proliferator-activated receptor-alpha (PPARalpha) activation attenuates cisplatin (CP)-mediated acute kidney injury by increasing fatty acid oxidation, but mechanisms leading to reduced renal triglyceride (TG) accumulation could also contribute. | Triglycerides | peroxisome proliferator activated receptor alpha | Mus musculus |
| 4 | Peroxisome proliferator-activated receptor-alpha (PPARalpha) activation attenuates cisplatin (CP)-mediated acute kidney injury by increasing fatty acid oxidation, but mechanisms leading to reduced renal triglyceride (TG) accumulation could also contribute. | Triglycerides | peroxisome proliferator activated receptor alpha | Mus musculus |